|
Geron Bio
tert immortalized retinal pigmented epithelial cell line Tert Immortalized Retinal Pigmented Epithelial Cell Line, supplied by Geron Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tert immortalized retinal pigmented epithelial cell line/product/Geron Bio Average 90 stars, based on 1 article reviews
tert immortalized retinal pigmented epithelial cell line - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Institut Curie
immortalized retinal pigment epithelial cell line htert ![]() Immortalized Retinal Pigment Epithelial Cell Line Htert, supplied by Institut Curie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/immortalized retinal pigment epithelial cell line htert/product/Institut Curie Average 90 stars, based on 1 article reviews
immortalized retinal pigment epithelial cell line htert - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: NAR Cancer
Article Title: The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest
doi: 10.1093/narcan/zcae011
Figure Lengend Snippet: AsiDNA™ induces a G1/S arrest in healthy cells in vitro . Cells were pulse-labelled with BrdU following incubation with 20 and 40 μM of AsiDNA™ for 24 and 48 h. Representative images of the bivariate analysis by flow cytometry of BrdU incorporation versus DNA content (PI) in ( A ) BJ and ( B ) RPE-hTERT cells. The deconvolution of the cellular DNA content frequency histograms allows the identification of G1 phase (purple), S-phase (orange), and G2/M-phase (green) in ( C ) BJ, and ( D ) RPE-hTERT cells. The percentage of cells in G1, S, and G2/M is shown in ( E ) for BJ, and in ( F ) for RPE-hTERT cells. Data are expressed as mean ± standard deviation ( n = 8–9) with significance given by two-way ANOVA, Tukey's multiple comparison tests, and represented above the bar plots. Statistical significance was set at * P value < 0.05, ** P value < 0.01, *** P value < 0.001 and **** P value < 0.0001.
Article Snippet: Immortalized retinal
Techniques: In Vitro, Incubation, Flow Cytometry, BrdU Incorporation Assay, Standard Deviation, Comparison
Journal: NAR Cancer
Article Title: The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest
doi: 10.1093/narcan/zcae011
Figure Lengend Snippet: AsiDNA™-induced G1/S arrest in vitro is dependent on DNA-PK, p53, and p21. ( A ) RPE-hTERT cells were pre-treated with 1 μM olaparib (Ola) or 10 μM NU7026 (NU) for 1 h before addition of 20 μM AsiDNA™. The percentage of cells in G1, S and G2/M was analysed by flow cytometry 48 h post-AsiDNA™ treatment based on PI staining. ( B ) RPE-hTERT cells were transiently transfected with small inhibitory RNA (siRNA) silencing DNA-PKcs, p53, or p21 before being exposed to AsiDNA™ for 48 h. The percentage of cells in G1, S and G2/M was analysed by flow cytometry based on PI staining. ( C ) MRC-5V1, ( D ) RPE-hTERT shp53 and ( E ) RPE-hTERT p21 −/− cells were treated with 20 and 40 μM of AsiDNA™ for 24 and 48 h. The percentage of cells in G1, S and G2/M was analysed by flow cytometry at the end of AsiDNA™ treatment based on PI staining. All the data are expressed as mean ± standard deviation ( n = 3–9) with significance given by two-way ANOVA, Tukey's multiple comparison tests, and represented above the bar plots. Statistical significance was set at * P value < 0.05, ** P value < 0.01, *** P value < 0.001 and **** P value < 0.0001.
Article Snippet: Immortalized retinal
Techniques: In Vitro, Flow Cytometry, Staining, Transfection, Standard Deviation, Comparison
Journal: NAR Cancer
Article Title: The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest
doi: 10.1093/narcan/zcae011
Figure Lengend Snippet: AsiDNA™ treatment protects p53-proficient normal cells, but not p53-proficient tumour cells, from radiation-induced toxicity in vitro . ( A ) p53 proficient normal cells (BJ and RPE-hTERT), ( B ) p53 deficient normal cells (RPE-hTERT shp53) and ( C ) p53 proficient tumour (HCT116 and A549) cells were pre-treated with AsiDNA™ 24 h before being co-exposed to increased doses of ionizing radiation (0–6 Gy). The survival fraction was determined 8–12 days post-treatment using a clonogenic survival assay. Data are expressed as mean ± standard deviation ( n = 3 for BJ, RPE-hTERT shp53, HCT116 and A549; n = 4 for RPE-hTERT), fitted to the linear-quadratic model as a function of dose with significance given by nonlinear fit using GraphPad Prism.
Article Snippet: Immortalized retinal
Techniques: In Vitro, Clonogenic Cell Survival Assay, Standard Deviation